Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials-Reference-Cited by-同舟云学术

Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials

Published:2010-03 Issue:3 Volume:51 Page:333-343
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:

Author:

Sperling Michael R.,Greenspan Andrew,Cramer Joyce A.,Kwan Patrick,Kälviäinen Reetta,Halford Jonathan J.,Schmitt Jennifer,Yuen Eric,Cook Thomas,Haas Magali,Novak Gerald

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1528-1167.2009.02318.x/fullpdf

Reference17 articles.

1. New antiepileptic drugs that are second generation to existing antiepileptic drugs;Bialer;Expert Opin Investig Drugs,2006

2. Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX);Bialer;Epilepsy Res,2009

3. Do we need any more new antiepileptic drugs?;Brodie;Epilepsy Res,2001

4. Pharmacokinetic interaction study between the new antiepileptic and CNS drug RWJ-333369 and carbamazepine in healthy adults;Chien;Epilepsia,2006

5. An interaction study between the new antiepileptic and CNS drug carisbamate (RWJ-333369) and lamotrigine and valproic acid;Chien;Epilepsia,2007

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cenobamate Plasma Levels in Patients with Epilepsy: Correlation with Efficacy and Tolerability?;Journal of Clinical Medicine;2024-05-08

2. Lennox-Gastaut Syndrome: Current Treatments, Novel Therapeutics, and Future Directions;Neurotherapeutics;2023-09

3. Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature;Medicina;2023-07-28

4. Concerted suppressive effects of carisbamate, an anti-epileptic alkyl-carbamate drug, on voltage-gated Na+ and hyperpolarization-activated cation currents;Frontiers in Cellular Neuroscience;2023-05-24

5. Anti-convulsant Agents: Cenobamate;NeuroPsychopharmacotherapy;2022